2014
DOI: 10.1039/c3ra42347f
|View full text |Cite
|
Sign up to set email alerts
|

A comparative study of the molecular structure, lipophilicity, solubility, acidity, absorption and polar surface area of coumarinic anticoagulants and direct thrombin inhibitors

Abstract: The methods of computational chemistry have been used to elucidate the molecular properties of coumarinic anticoagulants (acenocoumarol, phenprocoumon, warfarin and tecarfarin) and direct thrombin inhibitors (melagatran, dabigatran and their prodrug forms).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 15 publications
(22 citation statements)
references
References 70 publications
(89 reference statements)
0
22
0
Order By: Relevance
“…Dabigatran is a highly polar compound that does not undergo oxidative metabolism and is primarily excreted unchanged in the urine [29,31]. The predominant route of dabigatran metabolism is conjugation to glucuronic acid [29], with UGT2B15 serving as the major enzyme for metabolism and UGT1A9 and UGT2B7 serving as minor contributors to this process [38].…”
Section: Pharmacologic Basis For Extracorporeal Removalmentioning
confidence: 99%
See 1 more Smart Citation
“…Dabigatran is a highly polar compound that does not undergo oxidative metabolism and is primarily excreted unchanged in the urine [29,31]. The predominant route of dabigatran metabolism is conjugation to glucuronic acid [29], with UGT2B15 serving as the major enzyme for metabolism and UGT1A9 and UGT2B7 serving as minor contributors to this process [38].…”
Section: Pharmacologic Basis For Extracorporeal Removalmentioning
confidence: 99%
“…Extracorporeal removal is a potential consideration for treatment in the setting of dabigatran toxicity. An evaluation of dabigatran's pharmacological profile suggests that extracorporeal removal can expedite its clearance from plasma (Table 2) [1,2,[28][29][30][31][32]. Several authors have provided evidence to support extracorporeal removal as a strategy to manage dabigatran-related hemorrhage [32][33][34].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, as summarized in Annex 1, DOACs have a molecular weight that ranges between 435.88 and 627.73 g.mol -1 [18][19][20]. As expected, because it is a prodrug, dabigatran etexilate shows the highest molecular weight due to its ethyl group in the carboxylic acid and the hexyloxycarbonyl side chain in the amidine [20].…”
Section: Physicochemical Properties and Stock Solutions Of Doacsmentioning
confidence: 58%
“…Regarding polar surface area (PSA), dabigatran and dabigatran etexilate showed the highest values (150.22 and 154.05 Å, respectively Annex 1), while rivaroxaban exhibited the lowest value (88.18 Å) which may, together with the lower molecular weight, justify its higher bioavailability (around 80%, Annex 2) [18][19][20]. Indeed, drug permeability through biological membranes, such as small intestine and blood-brain-barrier, decreases as PSA increases [22,23].…”
Section: Physicochemical Properties and Stock Solutions Of Doacsmentioning
confidence: 99%
See 1 more Smart Citation